# COMPANIO — PHASE 12.2: BASELINE AUDIT & EXTERNAL EVIDENCE CLOSURE
## Pre-Closure Repository Audit, Governance Status & Verification Inventory

**Document Reference:** `docs/PHASE_12_2_BASELINE_AUDIT.md`  
**Milestone:** Phase 12.2 — External Evidence Closure & Pilot Authorization  
**Lead Roles:** Principal Healthcare Software Architect, Clinical Safety Engineer, Chief Information Security Officer  
**Baseline Git Commit:** `673fe7c`  
**Working Tree Status:** Clean  
**Audit Timestamp:** 2026-11-04  

---

## 1. Baseline Git & Codebase State

The engineering repository has been verified at commit `673fe7c` on branch `main` with a clean working tree.
The engineering test harness has been expanded from 12 to 13 automated test suites, incorporating the newly implemented pilot-safe de-identification and zero-PHI architecture engine:

1. `npm run test:deid` — **Phase 12.2 Pilot-Safe De-Identification Suite** (12/12 checks passing: HIPAA Safe Harbor direct identifier scrubbing, age brackets, Zero-PHI SMS/Email payloads, dynamic environment switches, and complex clinical narrative sanitization).
2. `npm run test:pilot` — **Phase 12 End-to-End Controlled Pilot** (11 stages, 43 assertions passing 100%).
3. `npm run test:recovery` — **Phase 12 Cryptographic Password Recovery** (10/10 security checks passing 100%).
4. `npm run test:drill` — **Phase 11 Backup & Restore Disaster Recovery Drill** (1058 documents, 100% bit parity, zero data loss).
5. `npm run test:operations` — **Phase 10 Release Gates A–E, Prometheus Metrics & Distributed Tracing** (100% passing).
6. `npm run test:redis` — **Phase 9.1 Redis 8.10.3 In-Memory/Real Engine Failure Injection** (8 scenarios passing 100%).
7. `npm run test:jobs` — **Phase 9 Distributed BullMQ Queues, 7 Workers, DLQ & Flag Preservation** (100% passing).
8. `npm run test:caregivers` — **Phase 8 Caregiver & Family Portal Integration** (10 suites, 15 REST APIs passing 100%).
9. `npm run test:reporting` — **Phase 7 Clinician Attestation & Traceable Reporting** (11 suites, 30 criteria passing 100%).
10. `npm run test:dialogue` — **Phase 6 Clinical Dialogue & Structured Observations** (77/77 checks passing 100%).
11. `npm run test:safety` — **Phase 5 Clinical Safety Net & 23 Tier-1/Tier-2 Triggers** (9 suites, 162/162 checks passing 100%).
12. `npm run test:voice` — **Phase 4 Hardened Voice Gateway & Audio Pipeline** (8 suites, 40/40 checks passing 100%).
13. `npm run build:client` — **Vite 5.4.21 Client Production Build** (Zero build errors, verified bundle output).

---

## 2. Review of Phase 12.1 Governance Documentation

Phase 12.1 established the complete governance framework, provider registers, clinical approval matrices, and human study protocol documents. A rigorous review of all Phase 12.1 outputs was conducted to ensure continuity and prevent contradictory claims:

1. **`docs/PHASE_12_1_BASELINE_AUDIT.md`**:
   - Reconciled engineering software completion vs external institutional governance readiness.
   - Identified the 5 gating domains: Vendor BAAs, External Penetration Testing, Institutional Clinical Sign-off, IRB Ethics Approval, and Real-Code Pilot-Safe Fallback.
2. **`docs/PHASE_12_1_PROVIDER_CONTRACT_REGISTER.md`**:
   - Audited the 5 external cloud vendors (AssemblyAI, Google Gemini, ElevenLabs, Twilio, Resend).
   - Documented lack of executed BAAs and established the mandatory requirement for a pilot-safe alternative architecture implemented in code.
3. **`docs/PHASE_12_1_PENETRATION_TEST_SCOPE.md`**:
   - Codified the 12 target attack surfaces, testing methodology, threat models, and explicit disclaimer that internal test scripts do NOT satisfy third-party penetration testing.
4. **`docs/PHASE_12_1_CLINICAL_APPROVAL_REGISTER.md`**:
   - Cataloged the 13 RED and 10 YELLOW clinical trigger rules, emergency guidance protocols, negation logic, and clinician attestation workflows awaiting formal board review.
5. **`docs/PHASE_12_1_HUMAN_FACTORS_RESULTS.md`**:
   - Detailed Protocol `COMPANIO-PILOT-2026-HFE`, laboratory bench validation (contrast ratios, minimum 48px touch targets, font scaling), and hardware staging setup.
   - Stated unequivocally that **no human participants have been enrolled** pending IRB ethics approval.
6. **`docs/PHASE_12_1_RISK_REMEDIATION_REGISTER.md`**:
   - Tracked 14 operational, clinical, security, and compliance risks across seven risk domains.
7. **`docs/PHASE_12_PRODUCTION_READINESS_MATRIX.md` & `docs/PHASE_12_1_FINAL_READINESS_ASSESSMENT.md`**:
   - Maintained the decoupled four-tier release taxonomy (Tier A: Synthetic PASS; Tier B: Usability Pilot CONDITIONAL; Tier C: Clinical Pilot BLOCKED; Tier D: Commercial Launch BLOCKED).

---

## 3. Scope of Phase 12.2 External Evidence Closure

Phase 12.2 advances the governance process from "Audit & Planning" to "Evidence Closure Tracking & Authorization Gating". The objectives of Phase 12.2 are:

1. **Execute Provider Agreement Tracking & Implement Pilot-Safe Architecture**:
   - Track contract owner, provider terms, data retention, and PHI eligibility for all 5 vendors.
   - **Crucial Requirement Fulfilled**: The pilot-safe de-identification and zero-PHI notification architecture has been **actually implemented and tested in code** (`server/src/services/privacy/deidentificationService.js`, `server/src/services/escalation/escalationDispatcher.js`, `server/src/tests/privacy/testPilotSafeDeidentification.js`), not merely documented.
2. **Establish External Penetration Testing Tracker**:
   - Track certified assessor engagement, approved 12-surface scope, rules of engagement, and findings registry. Explicitly note that execution status remains `PENDING EXTERNAL EXECUTION`.
3. **Establish Clinical Safety Sign-off Tracker**:
   - Track multi-physician clinical review of the 23 clinical hazard rules, negation logic, emergency guidance, and attestation workflow with identified clinical specialists.
4. **Establish Institutional Review Board (IRB) Approval Tracker**:
   - Track Protocol `COMPANIO-PILOT-2026-HFE` package review. Enforce statutory halt: zero human participants recruited or enrolled until formal written IRB approval is received.
5. **Document Lab Bench Human Factors Results & Hardware Staging**:
   - Reaffirm lab bench accessibility compliance (WCAG 2.1 AA, touch targets, contrast) and hardware tablet staging. Formally state zero human testing has occurred or will occur without IRB clearance.
6. **Publish Risk Remediation Closure Report**:
   - Re-evaluate all 14 risk items and determine closure status based on technical mitigations (such as the Zero-PHI engine) and external gate locks.
7. **Issue Final Production Readiness Assessment & Four-Tier Authorization**:
   - Formally decouple Tier A, Tier B, Tier C, and Tier D.
   - Enforce STOP GATE preventing human trials or commercial deployment until all external evidence is executed.
